This shows you the differences between two versions of the page.
Both sides previous revision Previous revision Next revision | Previous revision Next revision Both sides next revision | ||
research:pgx_drug_exposure [2015/03/10 15:30] rkboyce |
research:pgx_drug_exposure [2015/09/14 17:05] rkboyce |
||
---|---|---|---|
Line 11: | Line 11: | ||
**Coordinating Institution(s):** University of Pittsburgh, Medical University of Vienna, Columbia University, Regenstrief Institute, Janssen R&D, AstraZeneca | **Coordinating Institution(s):** University of Pittsburgh, Medical University of Vienna, Columbia University, Regenstrief Institute, Janssen R&D, AstraZeneca | ||
- | ** Additional Participants (currently seeking other collaborators):** Patrick Ryan, Jon Duke, George Hripcsak, Abraham G. Hartzema, Christian Reich | + | ** Additional Participants (currently seeking other collaborators):** Patrick Ryan, Jon Duke, George Hripcsak, Abraham G. Hartzema, Christian Reich, Dan Malone |
**Full Protocol:** [[https://docs.google.com/document/d/1u3AE5DtkEp3m8OcbwkGHtXBVefYGGJ_1RMO3OnqpXiY/edit|Google doc for the protocol]] | **Full Protocol:** [[https://docs.google.com/document/d/1u3AE5DtkEp3m8OcbwkGHtXBVefYGGJ_1RMO3OnqpXiY/edit|Google doc for the protocol]] | ||
Line 17: | Line 17: | ||
**Initial Proposal Date:** 2/16/2015 | **Initial Proposal Date:** 2/16/2015 | ||
- | **Launch Date:** //<fill out once finalized>// | + | **Launch Date:** 10/29/2015 |
**Study Closure Date: //<fill out once finalized>//** | **Study Closure Date: //<fill out once finalized>//** | ||
Line 38: | Line 38: | ||
===== Discussion ===== | ===== Discussion ===== | ||
- | //Post a thread letting everyone know about this new proposed study at [[http://forums.ohdsi.org/c/researchers]]// | + | [[http://forums.ohdsi.org/t/ohdsi-study-3-incidence-of-exposure-to-drugs-for-which-pre-emptive-pharmacogenomic-testing-is-available/387]] |
+ | |||
===== Datasets Run ===== | ===== Datasets Run ===== |